论文部分内容阅读
目的探讨锶-89治疗多发性骨转移瘤的疗效观察。方法多发性骨转移瘤患者50例,按1.48×108Bq(4mci)静脉注射2次治疗间隔3个月。结果完全缓解及部分缓解的患者41例(87.23%),10例患者出现白细胞及血小板下降,经升白药物治疗后恢复正常。结论锶-89治疗多发性骨转移瘤止痛效果好,毒副作用轻微,是一种当前较为理想的用于骨转移瘤止痛的临床药物。
Objective To investigate the efficacy of strontium-89 in the treatment of multiple bone metastases. Methods Fifty patients with multiple bone metastases were treated with intravenous injection of 1.48 × 108Bq (4mci) twice a day for 3 months. 41 patients (87.23%) had complete remission and partial remission, 10 patients had leukopenia and thrombocytopenia, and returned to normal after treatment with lightening agents. Conclusion Strontium-89 treatment of multiple bone metastases tumor pain effect, minor side effects, is currently a more ideal for the clinical treatment of bone metastases tumor drugs.